56.69
56.69 (0%)
As of Feb 14, 2025
Rhythm Pharmaceuticals, Inc. [RYTM]
Source:
Company Overview
Rhythm Pharmaceuticals, Inc. is a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases. We are focused on advancing our melanocortin-4 receptor (MC4R) agonists, including our lead asset, IMCIVREE (setmelanotide), as precision medicines designed to treat hyperphagia and severe obesity caused by MC4R pathway diseases.
Country | United States |
Headquarters | boston, massachusetts |
Phone Number | (857) 264-4280 |
Industry | manufacturing |
CEO | David P. Meeker M.D. |
Website | www.rhythmtx.com |